Pharmnovo Aktiebolag
556739-7368ActiveDeveloping non-addictive delta opioid receptor agonists for neuropathic pain.
Overview
- 1–4
- Employees
- 10–20M SEK
- Revenue
- 2007
- Founded
Key Decision Makers
Karin Rosén
Member of the Board
Olof Breuer
MD, Clinical pharmacology lead
Johan Lund
Chairman and Member of the Board
Per von Mentzer
CEO
+3 more contacts in Funnelfeedr
Description
PharmNovo AB is a clinical-phase pharmaceutical company based in Lund, Sweden, focused on addressing the significant unmet medical need in chronic and neuropathic pain management. The company specializes in developing novel compounds based on selective delta opioid receptor agonists (DORAs). Their p...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556739736801
Decision Makers
7 contacts in FunnelfeedrKarin Rosén
Member of the Board
Olof Breuer
MD, Clinical pharmacology lead
Johan Lund
Chairman and Member of the Board
Per von Mentzer
CEO
Bengt von Mentzer
Founder
Petra Larson
Communications lead
Other Contacts
Johan Dighed
Chair of Disciplinary Committee
Similar Companies
20 similar companies in FunnelfeedrSynartro AB
1–4 employeesDeveloping sustained local injection treatments for osteoarthritis pain relief.
Novo Nordisk Scandinavia AB
100–199 employeesGlobal healthcare leader developing innovative medicines for serious diseases.
Novo Nordisk Farma Oy
Novo Nordisk Finland develops life-changing treatments for chronic diseases.
AcuCort AB
1–4 employeesAcuCort develops and commercializes user-friendly, effective smart drugs.
VIFOR PHARMA NORDISKA AB
Global leader developing innovative therapies for iron deficiency and kidney disease.
Browse More
Pharmnovo Aktiebolag Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo